Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1404941.RAcFYHjlBhSxTLNphf7WNVPMI4QMP16oEEAF-voiR4GcA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1404941.RAcFYHjlBhSxTLNphf7WNVPMI4QMP16oEEAF-voiR4GcA130_assertion type Assertion NP1404941.RAcFYHjlBhSxTLNphf7WNVPMI4QMP16oEEAF-voiR4GcA130_head.
- NP1404941.RAcFYHjlBhSxTLNphf7WNVPMI4QMP16oEEAF-voiR4GcA130_assertion description "[In women receiving gonadotropin-releasing hormone agonist (n = 1) or oral contraceptives (n = 1), after the menopause (n = 2), and with irregular vaginal bleeding (n = 1), oxytocin receptor levels in leiomyoma and myometrium were unchanged but were reduced in anovulatory cycles (amenorrhea, n = 2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1404941.RAcFYHjlBhSxTLNphf7WNVPMI4QMP16oEEAF-voiR4GcA130_provenance.
- NP1404941.RAcFYHjlBhSxTLNphf7WNVPMI4QMP16oEEAF-voiR4GcA130_assertion evidence source_evidence_literature NP1404941.RAcFYHjlBhSxTLNphf7WNVPMI4QMP16oEEAF-voiR4GcA130_provenance.
- NP1404941.RAcFYHjlBhSxTLNphf7WNVPMI4QMP16oEEAF-voiR4GcA130_assertion SIO_000772 9757961 NP1404941.RAcFYHjlBhSxTLNphf7WNVPMI4QMP16oEEAF-voiR4GcA130_provenance.
- NP1404941.RAcFYHjlBhSxTLNphf7WNVPMI4QMP16oEEAF-voiR4GcA130_assertion wasDerivedFrom befree-2016 NP1404941.RAcFYHjlBhSxTLNphf7WNVPMI4QMP16oEEAF-voiR4GcA130_provenance.
- NP1404941.RAcFYHjlBhSxTLNphf7WNVPMI4QMP16oEEAF-voiR4GcA130_assertion wasGeneratedBy ECO_0000203 NP1404941.RAcFYHjlBhSxTLNphf7WNVPMI4QMP16oEEAF-voiR4GcA130_provenance.